Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb Ischemia
It can be concluded that the combination uses of BMSCs and miR-126 lead to more effective recovery from ischemic damage compared with using them alone. MiR-126 can be used as a strong modifier to reinforce the angiogenic potential, paracrine secretion, and survival of the BMSCs.
Authors
- Sahar Khajeh (ORCID: https://orcid.org/0000-0003-1614-2962)
- Kaoru Tabei (ORCID: https://orcid.org/0000-0001-9923-6969)
- Jafar Fallahi (ORCID: https://orcid.org/0000-0002-8485-9247)
- Pegah Nammian (ORCID: https://orcid.org/0000-0001-7967-0338)
- Vahid Razban (ORCID: https://orcid.org/0000-0002-8966-6081)
- Seyedeh-Leili Asadi-Yousefabad (ORCID: https://orcid.org/0000-0003-2643-7748)
- Seyyed Sajad Daneshi
Institutions
- Shiraz University (IR)
- Shiraz University of Medical Sciences (IR)
- Shahid Sadoughi University of Medical Sciences and Health Services (IR)
Publication Details
- Journal
- MicroRNA
- Published
- 2025-02-13
- DOI
- https://doi.org/10.2174/0122115366332247250124130611
- Citations
- 1
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81